Galleon Pharmaceuticals Demonstrates Successful Clinical Proof-of-Concept for Lead Product from Sleep Apnea Drug-Discovery Platform
Read more here


Ceptaris Resubmits New Drug Application (NDA) to FDA for Proprietary Gel Formulation of Mechlorethamine Hydrochloride
Read more here


Pennsylvania Has Enormous Untapped Potential for Investment, Says Venture Capitalist Kush Parmar
Read more here